{{scheme.chgp}}%
{{scheme.chgp}}%
No Matches Found
{{scheme.chgp}}%
No Matches Found
No Matches Found
OPKO Health Experiences Evaluation Revision Amid Mixed Market Signals and Performance Trends
OPKO Health, Inc. has experienced recent stock fluctuations, with a current price of $1.58. The technical indicators present a mixed outlook, showing both bullish and bearish signals across different time frames. While the stock has outperformed the S&P 500 in the short term, long-term returns remain negative.
Is OPKO Health, Inc. technically bullish or bearish?
As of October 3, 2025, OPKO Health, Inc. shows a mildly bullish trend supported by positive MACD and Bollinger Bands, although daily moving averages are mildly bearish, and while it has outperformed the S&P 500 recently, it has underperformed over the longer term.
Is OPKO Health, Inc. technically bullish or bearish?
As of October 3, 2025, OPKO Health, Inc. shows a mildly bullish technical trend with positive momentum from MACD and Bollinger Bands, despite some short-term weakness indicated by moving averages, while it has outperformed the S&P 500 recently but underperformed over the past three years.
Is OPKO Health, Inc. technically bullish or bearish?
As of October 3, 2025, OPKO Health, Inc. shows a mildly bullish technical trend supported by positive weekly indicators, despite mixed daily signals and underperformance over longer periods compared to the S&P 500.
OPKO Health Stock Soars 8.39%, Hits Intraday High of $1.55
OPKO Health, Inc. has seen a significant rise in stock price today, contrasting with the modest gain of the S&P 500. While the company has shown recent upward trends, its long-term performance remains challenged, marked by low profitability and declining net sales over the past year.
Is OPKO Health, Inc. technically bullish or bearish?
As of September 12, 2025, OPKO Health, Inc. is in a neutral trend with mixed indicators, having outperformed the S&P 500 in the short term but underperformed over the past year.
Is OPKO Health, Inc. overvalued or undervalued?
As of February 24, 2022, OPKO Health, Inc. is considered a risky investment due to its overvaluation indicated by a Price to Book Value of 0.85, a negative EV to EBITDA ratio of -6.52, and poor stock performance with a 1-year return of -6.79% compared to the S&P 500's 17.14%.
OPKO Health Hits Day High with Strong 8.63% Intraday Surge
OPKO Health, Inc. has seen a significant increase in its stock price today, contrasting with a slight decline in the S&P 500. The company has performed well over the past week and month, although its long-term performance remains challenging, marked by substantial declines over three and five years.
OPKO Health Experiences Revision in Stock Evaluation Amid Mixed Market Signals
OPKO Health, Inc. has recently experienced a revision in its market evaluation, with its stock showing fluctuations between $1.11 and $2.04 over the past year. Despite some mixed technical indicators, the company's performance has lagged behind the S&P 500, reflecting significant challenges in the competitive pharmaceuticals and biotechnology sector.
Is OPKO Health, Inc. overvalued or undervalued?
As of February 24, 2022, OPKO Health, Inc. is considered overvalued and risky due to negative earnings, poor financial ratios, and a current price of $1.27, especially when compared to healthier peers like Addus HomeCare Corp.
Is OPKO Health, Inc. technically bullish or bearish?
As of June 17, 2025, OPKO Health, Inc. is in a bearish trend, supported by bearish signals from the weekly MACD, Bollinger Bands, and daily moving averages, despite a bullish monthly KST indicating a divergence in longer-term trends.
Who are in the management team of OPKO Health, Inc.?
As of March 2022, the management team of OPKO Health, Inc. includes Dr. Phillip Frost (Chairman and CEO), Dr. Jane Hsiao (Vice Chairman and CTO), Dr. Jon Cohen (Executive Chairman of BioReference Laboratories), and Mr. Steven Rubin (Executive VP - Administration), along with several Independent Directors. This team offers a diverse range of expertise to the company.
What does OPKO Health, Inc. do?
OPKO Health, Inc. is a micro-cap healthcare company in the Pharmaceuticals & Biotechnology sector, reporting net sales of $150 million and a net loss of $68 million as of March 2025. The company has a market cap of approximately $1.06 billion and does not pay dividends.
How big is OPKO Health, Inc.?
As of Jun 18, OPKO Health, Inc. has a market capitalization of 1,061.48 million and reported net sales of 689.37 million with a net profit of -39.02 million over the latest four quarters. Shareholder's funds are 1,365.45 million, and total assets amount to 2,200.21 million.
{{list.post_title}}
{{list.post_excerpt}}
{{list.post_title}}
{{list.post_excerpt}}
